CTOs on the Move

Post Surgical Manufacturing

www.postsurgical.com

 
Post Surgical Manufacturing is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Avenda Health

Avenda Health is creating a more personalized future of prostate cancer care. Using deep learning, Avenda Health software maps a patient`s cancer in 3D, giving physicians precise information and the confidence to make care decisions. Dedicated to bringing this cutting-edge technology to all practices and physicians treating prostate cancer patients, Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.

Plak Smacker Inc

Plak Smacker Inc is a Corona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accuro Diagnostic Imaging

Accuro Diagnostic Imaging is a Ellenton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bosworth Company

Bosworth Company is a Skokie, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novadaq

Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to harmful ionizing radiation or contrast dye toxicity. More than 130 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs. The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT®, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.